megestrol acetate has been researched along with buserelin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bates, K; Blamey, RW; Nicholson, RI; Pearson, D; Robertson, JF | 1 |
| Blamey, RW; Griffiths, K; Pearson, D; Turkes, A; Williams, MR | 2 |
| Hickey, D; Soloway, MS; Todd, B | 1 |
| Bakker, GH; de Jong, FH; Henkelman, MS; Klijn, JG; Lamberts, SW; Setyono-Han, B; van der Schoot, P | 1 |
| Blankenstein, MA; de Jong, FH; Klijn, JG; Lamberts, SW | 1 |
| Soloway, MS | 1 |
| Klijn, JG | 1 |
1 trial(s) available for megestrol acetate and buserelin
| Article | Year |
|---|---|
LHRH-agonist treatment in clinical and experimental human breast cancer.
Topics: Administration, Intranasal; Breast Neoplasms; Buserelin; Cell Line; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Megestrol; Megestrol Acetate; Menopause; Menstrual Cycle; Progesterone; Prolactin; Receptors, Estradiol; Tamoxifen | 1985 |
7 other study(ies) available for megestrol acetate and buserelin
| Article | Year |
|---|---|
Comparison of two oestrogen receptor assays in the prediction of the clinical course of patients with advanced breast cancer.
Topics: Aged; Aging; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Immunoenzyme Techniques; Immunohistochemistry; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Predictive Value of Tests; Prognosis; Receptors, Estrogen; Sensitivity and Specificity; Tamoxifen | 1992 |
An objective biochemical assessment of therapeutic response in metastatic breast cancer: a study with external review of clinical data.
Topics: Biomarkers, Tumor; Blood Sedimentation; Bone Neoplasms; Breast Neoplasms; Buserelin; C-Reactive Protein; Carcinoembryonic Antigen; Female; Ferritins; Goserelin; Humans; Lung Neoplasms; Megestrol; Megestrol Acetate; Orosomucoid; Ovariectomy; Tamoxifen | 1990 |
Serum ferritin as a marker of therapeutic response in stage III and IV breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Buserelin; Female; Ferritins; Follow-Up Studies; Goserelin; Humans; Lung Neoplasms; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Staging; Ovariectomy; Remission Induction; Retrospective Studies; Tamoxifen | 1990 |
Pre-treatment testosterone levels: significance in androgen deprivation therapy.
Topics: Aged; Aged, 80 and over; Buserelin; Carcinoma; Diethylstilbestrol; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Male; Megestrol; Megestrol Acetate; Middle Aged; Orchiectomy; Prostatic Neoplasms; Testosterone | 1986 |
Comparison of the actions of the antiprogestin mifepristone (RU486), the progestin megestrol acetate, the LHRH analog buserelin, and ovariectomy in treatment of rat mammary tumors.
Topics: Animals; Body Weight; Buserelin; Combined Modality Therapy; Estrenes; Female; Follicle Stimulating Hormone; Luteinizing Hormone; Mammary Neoplasms, Experimental; Megestrol; Megestrol Acetate; Mifepristone; Ovariectomy; Rats; Rats, Inbred Strains; Receptors, Estrogen; Receptors, Progesterone | 1987 |
Newer methods of hormonal therapy for prostate cancer.
Topics: Adenocarcinoma; Aminoglutethimide; Androgen Antagonists; Bone Neoplasms; Buserelin; Flutamide; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Male; Megestrol; Megestrol Acetate; Pituitary Hormone-Releasing Hormones; Prostatic Neoplasms | 1984 |
Long-term LHRH-agonist treatment in metastatic breast cancer as a single treatment and in combination with other additive endocrine treatments.
Topics: Breast Neoplasms; Buserelin; Drug Therapy, Combination; Female; Humans; Megestrol; Megestrol Acetate; Tamoxifen | 1984 |